Yuflam-S Oral Drops contain a combination of Dicyclomine (10 mg) and Simethicone (40 mg) per dose, formulated to provide effective relief from gastrointestinal discomfort associated with functional bowel disorders. Dicyclomine is an anticholinergic agent that acts as an antispasmodic by inhibiting the muscarinic action of acetylcholine on smooth muscles of the gastrointestinal tract, thereby reducing intestinal motility and spasms. Simethicone is an anti-foaming agent that decreases bloating and discomfort caused by excess gas by coalescing gas bubbles, facilitating their expulsion. Yuflam-S is indicated for the symptomatic treatment of irritable bowel syndrome (IBS), abdominal cramps, and other conditions characterized by intestinal spasms and gas-related discomfort. The oral drops formulation allows for flexible dosing, particularly suitable for pediatric and geriatric populations. Administration should follow the prescribed dosage, and it is recommended to use the medication under medical supervision, especially in patients with known hypersensitivity to anticholinergic agents, glaucoma, or obstructive gastrointestinal diseases. Common side effects may include dry mouth, dizziness, and mild gastrointestinal disturbances. Yuflam-S Oral Drops provide a dual mechanism approach to managing gastrointestinal symptoms, improving patient comfort and quality of life.